Total and Regional Bone Mineral Content in Patients with Non-Insulin Dependent Diabetes Mellitus
スポンサーリンク
概要
- 論文の詳細を見る
Total body bone mineral content and bone mineral content in various body sites were measured by dual-photon absorptiometry in 103 patients with non-insulin-dependent diabetes mellitus (NIDDM) and the findings were compared with those for 214 non-diabetic control subjects matched for age and body weight. Neither total body bone mineral content (TBBM) nor the bone mineral density of the third lumbar vertebra (L3 BMD) in the diabetic subjects differed from the values in control subjects of either sex, but the values were significantly decreased in patients diseased for at least five years when compared with control subjects. Regional bone mineral measurement showed prominent bone loss in the truncal site, but no reduction in bone mass was found in the head, pelvis, arms, or legs in either male or female patients. These results suggest that reduced TBBM and L3 BMD are associated with duration of the disease and that a site-specific bone defect is present in NIDDM.
- 財団法人 学会誌刊行センターの論文
著者
-
HAGIWARA Satoshi
Second Department of Internal Medicine, Osaka City University Medical School
-
MIKI Takami
Second Department of Internal Medicine, Osaka City University Medical School
-
Hagiwara Satoshi
Second Department Of Internal Medicine Osaka City University Medical School
-
Nishizawa Yoshiki
Second Department Of Internal Medicine Osaka City University Medical School
-
MORII HIROTOSHI
Second Department of Internal Medicine Osaka City University
-
OKUNO Yasuhisa
Second Department of Internal Medicine, Osaka City University Medical School
-
SEKIYA Kiichiro
Second Department of Internal Medicine, Osaka City University Medical School
-
MIKI Takami
Second Department of Internal Medicine, Osaka City Medical School
関連論文
- -0146- Role of endothelium in hypotensive action of acetylcholine and bradylinin in spontaneously hypertensive rat.(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- Efficacy and safety of long-term oral falecalcitriol treatment in patients with renal osteodystrophy
- Clinical trial of in-situ hybridization method for the rapid diagnosis of sepsis
- Idiopathic portal hypertension associated with high serum titer of autoantibodies and liver dysfunction
- Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
- Efficacy of low-dose, intermittent eel calcitonin treatment for osteoporosis
- Synergistic Enhancement by 12-O-Tetradecanoylphorbol-13-acetate and Dibutyryl cAMP of 1α, 25-Dihydroxyvitamin D_3 Actionin Human Promyelocytic Leukemic HL-60 Cells
- Efficacy and safety of oral falecalcitriol in reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism
- 男性の骨粗鬆症に対する危険因子
- Insulin Secretion in Patients with Hyperthyroidism: in Relation to Abnormalities in Carbohydrate Metabolism
- Closer Correlation between Serum Triiodothyronine and Basal Metabolic Rate during Antithyroid Drug Treatment in Patients with Graves Disease
- Statement on the diagnosis and management of osteoporosis from the Consensus Development Conference at the Second International Conference on Osteoporosis,Osaka 1997
- A Case Report on Disequilibrium Hypercalcemia in Hyperthyroidism : Comparison of Calcium Metabolism with Other Patients with Hyperthyroidism
- Effect of Corticosteroids in 10 Cases of Methimazole-Induced Agranulocytosis
- Preventive Effect of Salmon Calcitonin on Restraint-Induced Gastric Ulcer in Rats
- Secretion of Gastrin and Calcitonin after Ingestion of Meat Extract in Patients with Peptic Ulcer
- A Case Report of Turner's Sydrome with Ring X Chromosome
- Effects of Uremic Serum on 1, 25-Dihydroxyvitamin D3-Induced Differentiation of a Human Promyelocytic Leukemia Cell Line, HL-60
- Lipoprotein Metabolism in Normolipidemic Obese Women during Very Low Calorie Diet:Changes in High Density Lipoprotein
- Effects of Dietary Phosphorus Restriction on Secondary Hyperparathyroidism in Hemodialysis Patients during Intermittent Oral High-dose 1, 25(OH)2D3 Treatment
- Obesity as a Determinant of Regional Bone Mineral Density
- Bone Mineral Loss in Patients on Maintenance Hemodialysis with Hyperphosphatemia Treated with 1α-Hydroxycholecalciferol and Calcium Carbonate
- Total and Regional Bone Mineral Content in Patients with Non-Insulin Dependent Diabetes Mellitus
- Cardiac Function and Exercise Capacity of Diabetic Patients
- Calcium Metabolism in Diabetes Mellitus
- Nutrition and Renal Osteodystrophy